Novavax is anticipated to start delivery of its COVID-19 vaccines to the European Union in Q1 of 2022, according to a report by Reuters on Monday.

  • Upon approval, the two-dose vaccine, referred to as Nuvaxovid, would be the 5th COVID-19 shot to be brought on to the EU market and come as the Omicron variant continues to spread.
  • Earlier this year, Novavax informed the EU of their plans to start making the first small shipments of its vaccine for the bloc, with major supplies in 2022.
  • The EU Commission and the company entered into a contract in August for the delivery of nearly 200 million dollars, of which 50% is optional.

The EU Commission did not issue an immediate response to the report, and the US biotech giant was not available to confirm the news. NVAX up +9.87%, Pre-market trading.